Parathyroid adenoma in a 15-year-old girl with recurrent urolithiasis

Authors

  • Patrycja Kucaba Department of Pediatrics Regional Hospital No.2, Rzeszow, Poland https://orcid.org/0009-0005-3374-3083
  • Katarzyna Dziadzio-Gąsior Department of Pediatrics Regional Hospital No.2, Rzeszow, Poland
  • Robert Podlasek Department of General Surgery Regional Hospital No.2, Rzeszow, Poland https://orcid.org/0000-0003-3065-1122
  • Piotr Bar Department of Pathomorphology Regional Hospital No.2, Rzeszow, Poland
  • Bartosz Korczowski Department of Pediatrics Regional Hospital No.2, Rzeszow, Poland; Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland https://orcid.org/0000-0003-1626-1283

DOI:

https://doi.org/10.15584/ejcem.2023.2.23

Keywords:

primary hyperparathyroidism, urolithiasis, pediatrics, hypercalcemia, kidney stones

Abstract

Introduction and aim. The incidence of urolithiasis in children has been growing steadily for several decades, and it accounts for an increasing percentage of hospitalizations. Kidney stones are deposits of various mineral salts. Most of them are composed of calcium, favored by hypercalcemia and hypercalciuria. Primary hyperparathyroidism is one of the reasons for increased calcium levels in the blood. 

Description of the case. A 15-year-old girl was hospitalized due to recurrent urolithiasis. Investigations revealed hypercalcemia with elevated parathyroid hormone. Ultrasound of the thyroid gland showed a local change near the lower pole of its right lobe, and Sestamibi nuclear scan confirmed the presence of the adenoma of the lower right parathyroid gland. Surgical removal of the parathyroid gland with the present adenoma was performed. Calcium and phosphate homeostasis parameters and the kidneys’ ultrasound image were without any significant deviations from the norm.

Conclusion. After finding the cause of recurrent urolithiasis, the applied surgical treatment resolved all disease manifestations. 

Downloads

Download data is not yet available.

References

Saadeh SA. Pediatric Nephrolithiasis: Risk Factors, Evaluation, and Prevention. Pediatr Ann. 2020;49(6):e262-e267. doi: 10.3928/19382359-20200518-01

Hernandez J, Ellison J, Lendvay T. Current Trends, Evaluation, and Management of Pediatric Nephrolithiasis. JAMA Pediatr. 2015;169(10):964-970. doi: 10.1001/jamapediatrics.2015.1419

Sas D, Becton L, Tutman J, Lindsay L, Wahlquist A. Clinical, demographic, and laboratory characteristics of children with nephrolithiasis. Urolithiasis. 2016;44(3):241-246. doi: 10.1007/s00240-015-0827-8

Van Batavia J, Tasian G. Clinical effectiveness in the diagnosis and acute management of pediatric nephrolithiasis. Int J Surg. 2016;36(Pt D):698-704. doi: 10.1016/j.ijsu.2016.11.030

VanDervoort K, Wiesen J, Frank R, et al. Urolithiasis in pediatric patients: A single center study of incidence, clinical presentation and outcome. J Urol. 2007;177(6):2300-2305. doi: 10.1016/j.juro.2007.02.002

Dwyer M, Krambeck A, Bergstralh E, Milliner D, Lieske J, Rule A. Temporal Trends in Incidence of Kidney Stones Among Children: A 25-Year Population Based Study. J Urol. 2012;188(1):247-252. doi: 10.1016/j.juro.2012.03.021

Scoffone C, Cracco C. Pediatric calculi: cause, prevention and medical management. Curr Opin Urol. 2018;28(5):428-432. doi: 10.1097/MOU.0000000000000520

Song L, Maalouf NM. Nephrolithiasis. In: Endotext. Feingold KR, Anawalt B, Boyce A, et al, ed. MDText.com, Inc; 2000.

Reusz G, Hosszu A, Kis E. Evaluation of a child with suspected nephrolithiasis. Review. Curr Opin Ped. 2020;32(2):265-272. doi: 10.1097/MOP.0000000000000880

Szmit-Domagalska J, Petriczko E, Chrupek M. Pierwotna nadczynność przytarczyc u 15-letniego chłopca. Ped Endocrinol. 2009;4:87-94. doi: 10.18544/EP-01.08.04.1180

Jamshidi R, Egan J. Pediatric parathyroid disease. Semin Pediatr Surg. 2020;29(3):150923. doi: 10.1016/j.sempedsurg.2020.150923

Pietkiewicz M, Nienartowicz E, Sokołowska-Dąbek D, Zaleska-Dorobisz U, Gamian A, Pietkiewicz J. Hyperparathyroidism: molecular, diagnostic and therapeutic aspects. Postepy Hig Med Dosw. 2010;64:555-567.

Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115-125. doi: 10.1038/nrendo.2017.104

Oberger Marques JV, Moreira CA. Primary hyperparathyroidism. Best Pract Res Clin Rheumatol. 2020;34(3):101514. doi: 10.1016/j.berh.2020.101514

Minisola S, Gianotti L, Bhadada S, Silverberg SJ. Classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):791-803. doi: 10.1016/j.beem.2018.09.001

Silverberg S, Walker M, Bilezikian J. Asymptomatic Primary Hyperparathyroidism. J Clin Dens. 2013;16(1):14-21. doi:10.1016/j.jocd.2012.11.005

Świrta JS, Romaniszyn M, Barczyński M. Pierwotna nadczynność przytarczyc. Leczenie operacyjne z uwzględnieniem technik małoinwazyjnych. Medycyna Praktyczna Chirurgia. 2018;1.

Ahmadieh H, Kreidieh O, Akl E, Fuleihan G. Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults. Cochrane Database Syst Rev. 2020;10(10):CD010787. doi: 10.1002/14651858.CD010787.pub2

Al.-Zahrani A, Al-Faraj J, Llaguno M, Alhussain A. Relationship Between Vesicoureteric Reflux and Nephrocalcinosis in Children: A Case-Control Study at a Tertiary Medical Center in Saudi Arabia. Cureus. 2022;14(10):e30650. doi: 10.7759/cureus.30650

Ruppe MD. X-Linked Hypophosphatemia. APR 2017. In: GeneReviews® [Internet]. Adam MP, Everman DB, Mirzaa GM, et al, ed. Seattle (WA): University of Washington, Seattle; 1993-2023.

Gietka-Czernel M, Kozakowski J, Szczepańska E. Zespół mnogich nowotworów gruczołów dokrewnych typu 1 (MEN1). Postępy Nauk Medycznych. 2017;30(12):665-673. doi: 10.25121/PNM.2017.30.12.665

Kobylecka M, Płazińska MT, Chudziński W, et al. Comparison of scintigraphy and ultrasound imaging in patients with primary, secondary and tertiary hyperparathyroidism–own experience. J Ultrason. 2017;17(68):17. doi: 10.15557/JoU.2017.0002

Downloads

Published

2023-06-30

How to Cite

Kucaba, P., Dziadzio-Gąsior, K., Podlasek, R., Bar, P., & Korczowski, B. (2023). Parathyroid adenoma in a 15-year-old girl with recurrent urolithiasis. European Journal of Clinical and Experimental Medicine, 21(2), 424–428. https://doi.org/10.15584/ejcem.2023.2.23

Issue

Vol. 21 No. 2 (2023)

Section

CASUISTIC PAPERS

License

Copyright (c) 2023 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.